Back

Empagliflozin impairs smooth muscle cell proliferation, accelerates endothelial regeneration, and prevents neointima formation by altered expression of the vasoactive peptide apelin

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Basic Science Vascular ePosters Drugs, Drug Targets ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Jochen Dutzmann

University Hospital Halle (Saale), Halle (Germany)

51 More presentations in this session

Presentation thumbnail
Human adventitial pericytes secrete bioactive factors exerting distinct biological effects on cardiac cells: hints for cardiac repair
Doctor E. Avolio (Bristol, GB)
Abstract Slides
Presentation thumbnail
Mechanisms of endothelial cell activation by endocannabinoid 2-arachidonoylglycerol
Doctor J. Jehle (Bonn, DE)
Abstract Slides
Presentation thumbnail
A novel senolytic drug, seno-7284 ameliorates aging phenotype and age-related cardiometabolic diseases
Doctor G. Katsuumi (Tokyo, JP)
Abstract Slides
Presentation thumbnail
iPSC-derived endothelial cells reflect accelerated senescence and increased inflammatory response in a CVD-risk stratified manner
Doctor E. Straessler (Berlin, DE)
Abstract Slides
Presentation thumbnail
Blocking of interleukin-1 suppresses both angiotensin II-induced renal inflammation and hypertension
Doctor T. Niida (Tokyo, JP)
Abstract Slides

Access the full session

Session thumbnail
Basic Science Vascular ePosters

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources